{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:17:36Z","timestamp":1783397856888,"version":"3.54.6"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001626","name":"Public Health Agency","doi-asserted-by":"publisher","award":["COM\/4965\/14"],"award-info":[{"award-number":["COM\/4965\/14"]}],"id":[{"id":"10.13039\/501100001626","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000771","name":"Prostate Cancer UK","doi-asserted-by":"publisher","award":["TLD-PF21-001"],"award-info":[{"award-number":["TLD-PF21-001"]}],"id":[{"id":"10.13039\/501100000771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["A29392"],"award-info":[{"award-number":["A29392"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008719","name":"Movember Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008719","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ctro.2026.101206","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T15:47:01Z","timestamp":1780156021000},"page":"101206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Impact of ataxia-telangiectasia mutated (ATM) loss on radiobiological and immune response to radium-223 in prostate cancer in vitro models"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8300-9948","authenticated-orcid":false,"given":"Victoria L.","family":"Dunne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9731-3120","authenticated-orcid":false,"given":"Timothy C.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8530-3366","authenticated-orcid":false,"given":"Aislinn","family":"Toner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa LaBonte","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4898-899X","authenticated-orcid":false,"given":"Kienan I.","family":"Savage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe M.","family":"O\u2019Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6134-7946","authenticated-orcid":false,"given":"Kevin M.","family":"Prise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2026.101206_b0005","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ctro.2026.101206_b0010","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.annonc.2020.06.011","article-title":"Prostate Cancer: ESME Clinical Practice guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Parker","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctro.2026.101206_b0015","first-page":"16","article-title":"Radiopharmaceutical Ra-223 Prostate Cancer Treeatment: where we are and where we are going","volume":"1","author":"Faria","year":"2018","journal-title":"British Journal of Cancer Research"},{"key":"10.1016\/j.ctro.2026.101206_b0020","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMoa1213755","article-title":"Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer","volume":"369","author":"Parker","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctro.2026.101206_b0025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrc1011","article-title":"ATM and related protein kinases: safeguarding genome integrity","volume":"3","author":"Shiloh","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ctro.2026.101206_b0030","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.molcel.2017.05.015","article-title":"ATM, ATR, and DNA-PK: the Trinity at the Heart of the DNA damage Response","volume":"66","author":"Blackford","year":"2017","journal-title":"Mol Cell"},{"key":"10.1016\/j.ctro.2026.101206_b0035","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","article-title":"Integrative Clinical Genomics of Advanced Prostate Cancer","volume":"161","author":"Dan","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ctro.2026.101206_b0040","article-title":"UK-based clinical testing programme for somatic and germline BRCA1\/2, ATM and CDK12 mutations in prostate cancer: first results. BMJ","volume":"4(1):e000592","author":"Evans","year":"2025","journal-title":"Oncol"},{"key":"10.1016\/j.ctro.2026.101206_b0045","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3390\/cancers12030687","article-title":"ATM-Deficient Cancers provide New Opportunities for Precision Oncology","volume":"12","author":"Jette","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ctro.2026.101206_b0050","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1158\/0008-5472.CAN-19-3126","article-title":"ATM loss Confers Greater Sensitivity to ATR Inhibition than PARP Inhibition in Prostate Cancer","volume":"80","author":"Rafiei","year":"2020","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctro.2026.101206_b0055","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.eururo.2016.11.033","article-title":"Germline Mutations in ATM and BRCA1\/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at death","volume":"71","author":"Na","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.ctro.2026.101206_b0060","article-title":"Inhibition of key DNA double strand break repair protein kinases enhances radiosensitivity of head and neck cancer cells to X-ray and proton irradiation","volume":"10(1):282","author":"Fabbrizi","year":"2024","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.ctro.2026.101206_b0065","article-title":"Inhibition of ATM increases the Radiosensitivity of Uveal Melanoma Cells to Photons and Protons","volume":"12(6):1388","author":"Hussain","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctro.2026.101206_b0070","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejca.2020.05.001","article-title":"Impact of DNA damage repair defects on response to radium-223 and overall survival in metastatic castration-resistant prostate cancer","volume":"136","author":"Van Der Doelen","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ctro.2026.101206_b0075","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.eururo.2018.09.040","article-title":"Efficacy of Radium-223 in Bone-metastatic Castration-resistant Prostate Cancer with and without Homologous Repair Gene Defects","volume":"76","author":"Velho","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.ctro.2026.101206_b0080","doi-asserted-by":"crossref","unstructured":"Al-Ezzi EM, Abdeljalil O, Lajkosk K, Gramolini SS, Alqaisi H, Peng J, et al. Survival outcomes for men with metastatic castration-resistant prostate cancer (mCRPC) with and without homologous recombination deficiencies (HRD) treated with radium 223: Princess Margaret Cancer Centre (PMCC) experience. Urologic oncology 2025; 43:665.e1-665.e10. https:\/\/doi.org\/ 10.1016\/j.urolonc.2025.06.004.","DOI":"10.1016\/j.urolonc.2025.06.004"},{"key":"10.1016\/j.ctro.2026.101206_b0085","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.3390\/cancers16081510","article-title":"Synergistic activity of DNA damage Response Inhibitors in Combination with Radium-223 in Prostate Cancer","volume":"16","author":"Dunne","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.ctro.2026.101206_b0090","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S1470-2045(09)70082-8","article-title":"Systemic effects of local radiotherapy","volume":"10","author":"Formenti","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2026.101206_b0095","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/S0140-6736(18)32486-3","article-title":"Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randmised controlled phase 3 trial","volume":"392","author":"Parker","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2026.101206_b0100","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw199","article-title":"Activation of STING-Dependent Innate Immune Signaling by S-Phase-Specific DNA damage in Breast Cancer","volume":"109","author":"Parkes","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ctro.2026.101206_b0105","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature23470","article-title":"Mitotic progression following DNA damage enables pattern recognition within micronuclei","volume":"548","author":"Harding","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ctro.2026.101206_b0110","doi-asserted-by":"crossref","DOI":"10.1002\/bies.202300045","article-title":"Harnessing the cooperation between DNA\u2010PK and cGAS in cancer therapies","volume":"45","author":"Taffoni","year":"2023","journal-title":"Bioessays"},{"key":"10.1016\/j.ctro.2026.101206_b0115","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1084\/jem.103.5.653","article-title":"Action of x-rays on mammalian cells","volume":"103","author":"Puck","year":"1956","journal-title":"J Exp Med"},{"key":"10.1016\/j.ctro.2026.101206_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.877302","article-title":"Differential responses to 223Ra and Alpha-particles exposure in prostate cancer driven by mitotic catastrophe","volume":"12","author":"Guerra Liberal","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ctro.2026.101206_b0125","doi-asserted-by":"crossref","first-page":"5640","DOI":"10.1158\/0008-5472.CAN-19-0859","article-title":"Cellular and Genetic Determinants of the Sensitivity of Cancer to \u03b1-Particle Irradiation","volume":"79","author":"Yard","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctro.2026.101206_b0130","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature12306","article-title":"cGAS produces a 2\u2032-5\u2032-linked cyclic dinucleotide second messenger that activates STING","volume":"498","author":"Ablasser","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ctro.2026.101206_b0135","article-title":"ATM inhibition enhance immunotherapy by activating STING signaling and augmenting MHC Class I","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ctro.2026.101206_b0140","doi-asserted-by":"crossref","DOI":"10.1093\/jbmrpl\/ziaf129","article-title":"ATM inhibition increases the anti-tumor efficacy of radium-223 (Ra-223) against prostate cancer bone metastasis in preclinical models","volume":"9","author":"Lefley","year":"2025","journal-title":"JBMR Plus"},{"key":"10.1016\/j.ctro.2026.101206_b0145","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nature01368","article-title":"DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation","volume":"421","author":"Bakkenist","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ctro.2026.101206_b0150","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/sj.cdd.4400874","article-title":"ATM, a central controller of cellular responses to DNA damage","volume":"8","author":"Khanna","year":"2001","journal-title":"Cell Death & Differentiation"},{"key":"10.1016\/j.ctro.2026.101206_b0155","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-02719-9","article-title":"DNA repair inhibitors sensitize cells differently to high and low LET radiation","volume":"11","author":"Bannik","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ctro.2026.101206_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0960-9822(99)80041-4","article-title":"A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase","volume":"9","author":"Blasina","year":"1999","journal-title":"Curr Biol"},{"key":"10.1016\/j.ctro.2026.101206_b0165","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/1078-0432.CCR-10-1215","article-title":"Tumor Suppressor CHK2: Regulator of DNA damage Response and Mediator of Chromosomal Stability","volume":"17","author":"Stolz","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ctro.2026.101206_b0170","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrm3546","article-title":"The ATM protein kinase: regulating the cellular response to genotoxic stress, and more","volume":"14","author":"Shiloh","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ctro.2026.101206_b0175","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1002\/jcp.22758","article-title":"Modulation of the tumor cell death pathway by androgen receptor in response to cytotoxic stimuli","volume":"226","author":"Frezza","year":"2011","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ctro.2026.101206_b0180","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1158\/1535-7163.MCT-04-0313","article-title":"Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer","volume":"4","author":"Liao","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ctro.2026.101206_b0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031052","article-title":"Androgen receptor drives cellular senescence","volume":"7","author":"Mirochnik","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ctro.2026.101206_b0190","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.6950","article-title":"Carbon ion irradiation exerts antitumor activity by inducing cGAS\u2013STING activation and immune response in prostate cancer\u2010bearing mice","volume":"13","author":"Hu","year":"2024","journal-title":"Cancer Med"},{"key":"10.1016\/j.ctro.2026.101206_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2025.156980","article-title":"ATM and ATR inhibition increases radiosensitivity and cGAS-STING activation in prostate cancer","volume":"193","author":"van Campen","year":"2025","journal-title":"Cytokine"},{"key":"10.1016\/j.ctro.2026.101206_b0200","doi-asserted-by":"crossref","unstructured":"Sun R, Jiang P, Wang Z, Yan B, Zhu S, Huang Z, et al. DNA2 protein destruction dictates DNA hyperexcision, cGAS\u2013STING activation, and innate immune response in CDK12-deregulated cancers. Proceedings of the National Academy of Sciences 2025;122. https:\/\/doi.org\/10.1073\/pnas.2413732122.","DOI":"10.1073\/pnas.2413732122"},{"key":"10.1016\/j.ctro.2026.101206_b0205","doi-asserted-by":"crossref","first-page":"492","DOI":"10.18632\/aging.204487","article-title":"Selective ATM inhibition augments radiation-induced inflammatory signaling and cancer cell death","volume":"15","author":"Chiu","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.ctro.2026.101206_b0210","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007474","article-title":"ATM inhibition augments type I interferon response and antitumor T-cell immunity when combined with radiation therapy in murine tumor models","volume":"11","author":"Jin","year":"2023","journal-title":"J Immunother Cancer"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826001011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826001011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:44:58Z","timestamp":1783395898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630826001011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":42,"alternative-id":["S2405630826001011"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101206","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of ataxia-telangiectasia mutated (ATM) loss on radiobiological and immune response to radium-223 in prostate cancer in vitro models","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101206","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101206"}}